Question 1

What are the potential side effects of ALKS 3831?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia clinical trial (NCT02873208). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia clinical trial (NCT02873208). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the study visits involve, and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia clinical trial (NCT02873208). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks I should be aware of before participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia clinical trial (NCT02873208). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia clinical trial (NCT02873208). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia clinical trial (NCT02873208). Contact the study team or your healthcare provider for specific answers.

What this study is about